association

Full identifier: http://purl.org/np/RAMDl6w7lXZQYDUuT98vjAY5zXIoMStqKs-H3bdtrZKLU#association

Assigned to 1 class:

Minted in Nanopublication

 RAMDl6w7lX comment approve/disapprove edit as derived nanopublication create new with same template

This is a local identifier that was minted when the nanopublication was created. http://purl.org/np/RAMDl6w7lX...#association association https://w3id.org/biolink/vocab/has_population_context has_population_context This is a local identifier that was minted when the nanopublication was created. http://purl.org/np/RAMDl6w7lX...#context context .
This is a local identifier that was minted when the nanopublication was created. http://purl.org/np/RAMDl6w7lX...#context context http://www.w3.org/2000/01/rdf-schema#label label "Children and adolescents (6-17 years)" .
This is the identifier for this whole nanopublication. http://purl.org/np/RAMDl6w7lX... This nanopublication links to the assertion template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate was created from the assertion template http://purl.org/np/RAhNHZw6Ur... RAhNHZw6Ur .
This is a local identifier minted within the nanopublication. http://purl.org/np/RAMDl6w7lX...#sig sig http://purl.org/nanopub/x/hasSignatureTarget has as target This is the identifier for this whole nanopublication. http://purl.org/np/RAMDl6w7lX... this nanopublication .
This is a local identifier minted within the nanopublication. http://purl.org/np/RAMDl6w7lX...#sig sig http://purl.org/nanopub/x/hasAlgorithm has the algorithm (this is a literal) "RSA" .

0000-0002-7641-6446, 24 Aug 2021, 15:53:57 UTC

References

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
0000-0002-7641-6446
2021-08-24T15:53:57.790Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Paliperidone is FDA-approved for schizophrenia aged 12-17. However, the pharmacologic portfolio, extrapolation from adult studies, and the long track record of the parent drug, risperidone in child/adolescent psychiatric (CAP) population might expand its therapeutic potential. An 8-week open-label study [9] examined paliperidone monotherapy for acute mania, mixed, or hypomanic episode in pediatric patients (n = 15, 6–17 years of age) with bipolar spectrum disorders. At the end of follow-up period, 11 subjects (73%) completed the study; treatment with paliperidone was associated with a 60% response rate (50% decrease in the Young Mania Rating Scale) and 40% remission (YMRS <12)
0000-0002-7641-6446
2021-08-24T15:53:57.790Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
0000-0002-7641-6446
2021-08-24T15:53:57.790Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
0000-0002-7641-6446
2021-08-24T15:53:57.790Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
0000-0002-7641-6446
2021-08-24T15:53:57.790Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
0000-0002-7641-6446
2021-08-24T15:53:57.790Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
0000-0002-7641-6446
2021-08-24T15:53:57.790Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
0000-0002-7641-6446
2021-08-24T15:53:57.790Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
0000-0002-7641-6446
2021-08-24T15:53:57.790Z

Raw

TriG(txt), JSON-LD(txt), N-Quads(txt), XML(txt)